| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000019648 |
| Receipt No. | R000022706 |
| Official scientific title of the study | Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant. |
| Date of disclosure of the study information | 2015/11/05 |
| Last modified on | 2016/04/11 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Tracheal intubating conditions using sevoflurane and remifentanil target-controlled infusions without muscle relaxant. | |
| Title of the study (Brief title) | tracheal intubating conditions with remifentanil TCI. | |
| Region |
|
|
| Condition | ||||
| Condition | otological patients without muscle relaxant | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | We aimed to determine the most appropriate dose of remifentanil required for intubation using target -controlled infusion(TCI). |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Intubating score
Blood pressure, heart rate of intubation Dose of vasopressor agent |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Dose comparison |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | remifentanil TCI 15 ng/ml(effect site concentration) | |
| Interventions/Control_2 | remifentanil TCI 10 ng/ml(effect site concentration) | |
| Interventions/Control_3 | remifentanil TCI 5 ng/ml(effect site concentration) | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | otological patients without muscle relaxant | |||
| Key exclusion criteria |
Patients who refuse to participate this study Patients who have severe cardiovascular disease |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Manabu Yoshimura |
| Organization | Tokuyama Central Hospital |
| Division name | Department of anesthesiology |
| Address | 1-1 Kodaco, Shunan-city 745-0825 |
| TEL | 0834-22-4411 |
| manabu-ygc@umin.ac.jp | |
| Public contact | |
| Name of contact person | Manabu Yoshimura |
| Organization | Tokuyama Central Hospital |
| Division name | Department of Anesthesiology |
| Address | 1-1 Kodacyo, Shunan-city |
| TEL | 0834-22-4411 |
| Homepage URL | |
| manabu-ygc@umin.ac.jp | |
| Sponsor | |
| Institute | Tokuyama Central Hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Tokuyama Central Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | JCHO徳山中央病院(山口県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-bin/ctr_e/ctr_view.cgi?recptno=R000022706 |